Holdings
Opaleye Management Inc.
As of Jun 30, 2026, Opaleye Management Inc. reported 54 positions worth US$1.01B. Largest: Liquidia Corporation, Eton Pharmaceuticals, Inc. and Harrow, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Liquidia Corporation | 2.45M | US$195M | −97,500 | Jun 30, 2026 |
| Eton Pharmaceuticals, Inc. | 2.86M | US$104M | no change | Jun 30, 2026 |
| Harrow, Inc. | 2.4M | US$102M | −432K | Jun 30, 2026 |
| Disc Medicine, Inc. | 855K | US$62.5M | +434K | Jun 30, 2026 |
| Apogee Therapeutics, Inc. | 390K | US$51.8M | no change | Jun 30, 2026 |
| Meiragtx Holdings Plc | 3.55M | US$48M | +1.43M | Jun 30, 2026 |
| Rezolute, Inc. | 6.3M | US$32.8M | no change | Jun 30, 2026 |
| Tg Therapeutics, Inc. | 535K | US$29.4M | no change | Jun 30, 2026 |
| Immix Biopharma, Inc. | 2.35M | US$24.2M | new | Jun 30, 2026 |
| Crescent Biopharma, Inc. | 1.32M | US$23.7M | +6,736 | Jun 30, 2026 |